Electrocore (NASDAQ:ECOR) Director Carrie Smith Cox acquired 7,300 shares of the business’s stock in a transaction dated Monday, December 3rd. The stock was acquired at an average price of $6.79 per share, for a total transaction of $49,567.00. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.
ECOR opened at $6.35 on Friday. Electrocore has a 52-week low of $5.40 and a 52-week high of $20.25.
Electrocore (NASDAQ:ECOR) last posted its quarterly earnings data on Tuesday, November 13th. The company reported ($0.45) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.45). The company had revenue of $0.15 million for the quarter. Equities research analysts forecast that Electrocore will post -1.13 earnings per share for the current year.
Institutional investors and hedge funds have recently bought and sold shares of the business. Hodges Capital Management Inc. lifted its holdings in Electrocore by 56.9% during the third quarter. Hodges Capital Management Inc. now owns 839,302 shares of the company’s stock valued at $11,750,000 after purchasing an additional 304,302 shares in the last quarter. Orbimed Advisors LLC purchased a new position in Electrocore during the second quarter valued at $6,568,000. Citadel Advisors LLC purchased a new position in Electrocore during the second quarter valued at $427,000. Millennium Management LLC purchased a new position in Electrocore during the second quarter valued at $724,000. Finally, Point72 Asset Management L.P. purchased a new position in Electrocore during the second quarter valued at $206,000. 16.31% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This story was published by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.themarketsdaily.com/2018/12/07/insider-buying-electrocore-ecor-director-acquires-49567-00-in-stock.html.
Electrocore Company Profile
electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. It is developing gammaCore, a prescription-only vagus nerve stimulation therapy, for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Read More: Google Finance
Receive News & Ratings for Electrocore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electrocore and related companies with MarketBeat.com's FREE daily email newsletter.